CDMO SK Pharmteco has announced plans to invest $260 million in a new small molecule and peptide facility in Sejong, South Korea, the fifth in its home country and the cornerstone of its global manufacturing network. This is scheduled to begin operations in late 2026, creating over 300 jobs.